BIOC News and Press, Biocept Inc. From 09/08/23

Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products, and services, announces the signing of a non-exclusive licensing agreement for CNSide™ with Plus Therapeutics, Inc. (Nasdaq: PSTV) (Plus), which expands the comprehensive laboratory services agreem...

Biocept, Inc. (Nasdaq: BIOC) (“Biocept” or the “Company”), a leading provider of molecular diagnostic assays, products and services, announces that management will participate in the H.C. Wainwright 25 th Annual Global Investment Conference being held September 1...

2023-08-30 20:38:10 ET Biocept, Inc. (BIOC) Business Update Conference Call August 30, 2023 4:00 PM ET Company Participants Jody Cain - LHA Antonino Morales - President, CEO Dr. Barbara Blouw - VP, Clinical Development Dr. Seema Nagpal - Clinical Professor of...

Biocept, Inc. (Nasdaq: BIOC) management will hold a conference call on August 30, 2023, beginning at 4:00 p.m. Eastern time (1:00 p.m. Pacific time) to provide a business update and to answer questions. Participants can pre-register for the conference call here . Callers who pre-registe...

2023-08-14 17:12:16 ET Biocept press release ( NASDAQ: BIOC ): Q2 GAAP EPS of -$3.50. Revenue of $0.59M (-89.9% Y/Y) misses by $1.06M . Shares +7.27% AH. For further details see: Biocept GAAP EPS of -$3.50, revenue of $0.59M misses by $1.06M

Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, reports financial results for the three and six months ended June 30, 2023 and provides a business update. “Biocept’s primary focus is establishing our proprietary cerebrosp...

Biocept, Inc . (Nasdaq: BIOC) (“Biocept” or the “Company”), a leading provider of molecular diagnostic assays, products and services, announces that its CNSide cerebrospinal fluid assay was featured in two oral presentations at the 2023 SNO/ASCO CNS Cancer Conferen...

Biocept, Inc . (Nasdaq: BIOC) (“Biocept” or the “Company”) announces that M. Faye Wilson, Board Chair, passed away unexpectedly on Monday, July 10. The Board of Directors and staff of Biocept extend their deepest condolences to the Wilson family and express their gra...

2023-06-27 08:40:16 ET American Equity Investment Life  ( AEL ) +16% Reinsurance makes $55 per share offer for American Equity Investment. AC Immune ( ACIU ) +15% receives FDA Fast Track designation for Anti-Amyloid-beta active Immunotherapy, ACI-24.060, to Trea...

2023-06-20 16:30:30 ET Biocept ( NASDAQ: BIOC ) on Tuesday said it had named its interim CFO Antonino Morales as its new CEO, effective immediately. Morales will replace Samuel Riccitelli, who has resigned as interim president and CEO. According to BIOC, Morales h...